Product logins

Find logins to all Clarivate products below.


PACS, RIS, and CVIS | Medtech 360 | Market Analysis | Europe | 2018

Europe continues to face an increasingly aging population, contributing to rising radiology and cardiology procedure volumes from higher incidences of chronic illness and consequently supporting the markets for radiology PACS, RIS, and CVIS. However, market saturation driving increased price competition among vendors, healthcare system budgetary constraints, and an increasing shift toward enterprise solutions will limit market growth to a significant degree. 

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for PACS, RIS, and CVIS in Europe across a 10-year period.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Infusion Pumps – Market Insights – Europe
The European infusion pump demand will be underpinned by aging populations and rising chronic disease, while accelerating adoption of closed-loop, EHR-integrated smart pumps and growing demand of…
Report
Laparoscopic Devices – Market Insights – Europe
Laparoscopic procedure volumes in Europe will grow only modestly through 2034, with notable variation across procedure types. Bariatric and colorectal laparoscopic surgeries are expected to…
Report
Sports Medicine Devices – Market Insights – Europe
The Europe sports medicine device market will grow modestly through 2034, driven by growing demand for sports medicine procedures, uptake of premium-priced products, increased availability and…
Report
Physician-Dispensed Cosmeceuticals – Market Insights – Europe
The European physician-dispensed cosmeceutical market will be driven by rising aesthetic consciousness, an aging population, and increasing demand for clinically validated skincare solutions. The…